TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
The current TG Therapeutics(TGTX) stock price is $30.22, with a market capitalization of 4.83B. The stock trades at a price-to-earnings (P/E) ratio of 10.99.
On 2026-03-24, TG Therapeutics(TGTX) stock traded between a low of $29.72 and a high of $30.49. Shares are currently priced at $30.22, which is +1.7% above the low and -0.9% below the high.
The TG Therapeutics(TGTX)'s current trading volume is 1.47M, compared to an average daily volume of 2.68M.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $46.48 at its peak.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $46.48 at its peak.
TGTX News
TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described...
An announcement from TG Therapeutics ( (TGTX) ) is now available. TG Therapeutics filed a very limited Form 8-K current report that merely cross-references inf...
(RTTNews) - TG Therapeutics, Inc. (TGTX), a commercial stage biopharmaceutical company, Thursday announced that it has obtained a new five-year, $750 million se...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.